A Study to Evaluate Central Nervous System (CNS) Pharmacodynamic Activity of TAK-653 in Healthy Participants Using Transcranial Magnetic Stimulation (TMS)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 11, 2019

Primary Completion Date

May 15, 2019

Study Completion Date

June 18, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-653

TAK-653 tablets.

DRUG

Placebo

TAK-653 placebo-matching tablets.

DRUG

Ketamine

Ketamine intravenous infusion.

Trial Locations (1)

CHDR, Leiden